Underwriters Shouldn't Be Reading Lab Reports
Underwriters Shouldn't Be Reading Lab Reports The Manual COA Problem Is Becoming One of the Biggest Compliance Gaps in Regulated Payment...
Ohio Governor Mike DeWine is expected to announce executive action restricting intoxicating hemp products including THC-infused drinks and gummies sold at gas stations, bars, and retail shops across the state, following months of legislative inaction on the issue.
DeWine scheduled a press conference for 2:30 p.m. on October 8 in downtown Columbus to announce what actions he will take against intoxicating hemp products. The governor could sign an executive order to crack down on sales of THC-infused beverages and gummies currently available outside the state's licensed marijuana dispensary system.
The anticipated action follows DeWine's January 2024 call for Ohio lawmakers to restrict access to intoxicating hemp products. At that time, the governor stated, "The current loophole that allows these dangerous products to be sold to children needs to be closed as soon as possible."
State legislators have not enacted proposed laws that would require intoxicating hemp products such as delta-8 THC to be sold exclusively in licensed marijuana dispensaries or impose THC limits on beverages. The legislative proposals stalled due to lawmakers' lack of consensus on various marijuana-related questions that have remained unresolved since Ohio voters legalized recreational marijuana in a 2023 ballot measure.
Ohio's current situation stems from the 2018 federal Farm Bill, which legalized hemp nationwide and defined it as cannabis containing no more than 0.3% delta-9 THC, the primary psychoactive compound in marijuana. While the law intended to facilitate industrial hemp and CBD markets, it created legal pathways for CBD stores, breweries, and gas stations to sell hemp-derived cannabis products and other substances existing in regulatory gray areas.
The distinction between delta-9 THC concentrations in hemp versus marijuana products allows manufacturers to create intoxicating products that technically comply with federal hemp definitions while producing effects similar to traditional marijuana products. These products have proliferated in retail channels not licensed or regulated under Ohio's marijuana program.
Ohio's licensed marijuana dispensaries must sell products in child-resistant packaging and comply with testing, labeling, and potency requirements. Intoxicating hemp products sold through general retail channels are not subject to the same restrictions, creating what regulators characterize as a two-tier system with different safety standards.
Anticipating the announcement, retailers began selling off inventory on October 7. The Rambling House, a Columbus-based establishment, posted to Instagram: "We actually want good regulations: age limits, milligram caps, proper retail licensing. That's all reasonable. But this sudden ban will hurt small businesses, retailers and manufacturers."
The response reflects industry preference for regulatory frameworks over prohibition. Retailers argue that their products are marketed to and purchased by adults, and that appropriate regulations could address safety concerns without eliminating legal businesses that have developed around intoxicating hemp products.
Beer and wine shops that added THC-infused beverages to their product offerings attempted to clear inventory before the rumored ban takes effect. Grocers and small businesses have pushed back against proposed bans, noting the economic impact on establishments that incorporated these products into their business models based on the existing legal framework.
Questions remain about how executive action would address products already in the distribution chain, whether retailers would receive compensation for unsellable inventory, and what timeline businesses would have to comply with new restrictions.
Ohio Poison Centers data indicates over 800 children ages 12 and younger were exposed to cannabis in 2024, representing a 52% increase from the previous year. Nearly all cases involved marijuana edibles in forms such as candy, gummies, and brownies.
The pediatric exposure statistics provide context for public health concerns driving regulatory action. However, data does not distinguish between exposures involving licensed dispensary products subject to child-resistant packaging requirements and intoxicating hemp products sold through general retail channels.
Questions about whether specific packaging and marketing practices contribute to pediatric exposures and whether regulatory requirements rather than prohibition would adequately address safety concerns remain part of ongoing policy debates.
Other states have addressed intoxicating hemp product regulation through various approaches. Some states have enacted legislation explicitly restricting delta-8 and other hemp-derived intoxicants to licensed marijuana dispensaries. Others have implemented potency limits, age restrictions, and packaging requirements for hemp products while allowing sales through general retail channels.
Minnesota enacted comprehensive hemp-derived cannabinoid regulations in 2023, creating a regulatory framework with testing requirements, potency limits, and retail licensing for products sold outside marijuana dispensaries. Colorado restricted sales of intoxicating hemp products to licensed marijuana stores. Texas implemented testing and labeling requirements while allowing general retail sales.
The variation in state approaches reflects different policy priorities regarding consumer access, small business protection, public health, and regulatory resource allocation. Ohio's approach through potential executive action rather than legislation may differ from states that developed frameworks through legislative processes allowing stakeholder input.
If Governor DeWine issues an executive order restricting intoxicating hemp products, implementation details will determine impacts on retailers, consumers, and public health outcomes. Key questions include whether restrictions would apply to all hemp-derived cannabinoids or specific compounds, what THC concentration thresholds would trigger restrictions, and whether existing products would be grandfathered or immediately prohibited.
The relationship between executive action and potential future legislation remains unclear. Executive orders can be reversed by subsequent governors or superseded by legislative action, creating uncertainty for businesses attempting to plan long-term strategies in Ohio's hemp and marijuana markets.
Enforcement mechanisms and which state agencies would oversee compliance with new restrictions require clarification. Ohio's current system involves multiple agencies overseeing different aspects of marijuana and hemp regulation, and how executive action would coordinate or modify these jurisdictions affects implementation feasibility.
The intoxicating hemp product category lacks standardized terminology, testing protocols, and labeling requirements across jurisdictions. Products marketed as "delta-8," "delta-10," "THC-O," and other cannabinoid variants have different chemical properties, potencies, and safety profiles that complicate regulatory approaches.
Manufacturing processes for some hemp-derived intoxicants involve chemical conversions that raise safety questions distinct from those associated with naturally occurring cannabinoids in marijuana. Regulatory frameworks designed for plant-based marijuana products may not adequately address synthetically derived or chemically modified cannabinoids.
Testing infrastructure to identify and quantify various hemp-derived cannabinoids requires development in many states. Without standardized testing, enforcing potency limits or product restrictions presents practical challenges for regulatory agencies with limited resources.
As states implement varying restrictions on intoxicating hemp products and hemp-derived cannabinoids, manufacturers and retailers need real-time regulatory monitoring to maintain compliance across multiple jurisdictions. Qredible's Q-Trust quality management system provides automated regulatory tracking, product testing documentation, and multi-state compliance management specifically designed for businesses in highly regulated cannabinoid markets. Schedule a discovery call to learn how our cannabis and hemp compliance solutions can help your business adapt to rapidly changing state regulations while maintaining product quality and operational continuity.
